INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY
ENVIRONMENTAL HEALTH CRITERIA 158
AMITROLE
This report contains the collective views of an international group of
experts and does not necessarily represent the decisions or the stated
policy of the United Nations Environment Programme, the International
Labour Organisation, or the World Health Organization.
Published under the joint sponsorship of
the United Nations Environment Programme,
the International Labour Organisation,
and the World Health Organization
First draft prepared by Dr P.J. Abbott,
Department of Health, Housing and
Community Services, Canberra, Australia
World Health Orgnization
Geneva, 1994
The International Programme on Chemical Safety (IPCS) is a
joint venture of the United Nations Environment Programme, the
International Labour Organisation, and the World Health
Organization. The main objective of the IPCS is to carry out and
disseminate evaluations of the effects of chemicals on human health
and the quality of the environment. Supporting activities include
the development of epidemiological, experimental laboratory, and
risk-assessment methods that could produce internationally
comparable results, and the development of manpower in the field of
toxicology. Other activities carried out by the IPCS include the
development of know-how for coping with chemical accidents,
coordination of laboratory testing and epidemiological studies, and
promotion of research on the mechanisms of the biological action of
chemicals.
WHO Library Cataloguing in Publication Data
Amitrole.
(Environmental health criteria ; 158)
1.Amitrole - standards 2.Environmental exposure
3.Herbicides I.Series
ISBN 92 4 157158 6 (NLM Classification: WA 240)
ISSN 0250-863X
The World Health Organization welcomes requests for permission
to reproduce or translate its publications, in part or in full.
Applications and enquiries should be addressed to the Office of
Publications, World Health Organization, Geneva, Switzerland, which
will be glad to provide the latest information on any changes made
to the text, plans for new editions, and reprints and translations
already available.
(c) World Health Organization 1994
Publications of the World Health Organization enjoy copyright
protection in accordance with the provisions of Protocol 2 of the
Universal Copyright Convention. All rights reserved.
The designations employed and the presentation of the material
in this publication do not imply the expression of any opinion
whatsoever on the part of the Secretariat of the World Health
Organization concerning the legal status of any country, territory,
city or area or of its authorities, or concerning the delimitation
of its frontiers or boundaries.
The mention of specific companies or of certain manufacturers'
products does not imply that they are endorsed or recommended by the
World Health Organization in preference to others of a similar
nature that are not mentioned. Errors and omissions excepted, the
names of proprietary products are distinguished by initial capital
letters.
CONTENTS
1. SUMMARY
1.1. Identity, physical and chemical properties, and analytical
methods
1.2. Sources of human and environmental exposure
1.3. Environmental transport, distribution and transformation
1.4. Environmental levels and human exposure
1.5. Kinetics and metabolism in laboratory animals and humans
1.6. Effects on experimental animals and in vitro systems
1.7. Effects on humans
1.8. Effects on other organisms in the laboratory and field
2. IDENTITY, PHYSICAL AND CHEMICAL PROPERTIES AND ANALYTICAL
METHODS
2.1. Identity
2.2. Physical and chemical properties
2.3. Conversion factors
2.4. Analytical methods
2.4.1. Plants
2.4.2. Soil
2.4.3. Water
2.4.4. Formulations
2.4.5. Air
2.4.6. Urine
3. SOURCES OF HUMAN AND ENVIRONMENTAL EXPOSURE
3.1. Natural occurrence
3.2. Anthropogenic sources
3.2.1. Production levels and processes
3.2.2. Uses
4. ENVIRONMENTAL TRANSPORT, DISTRIBUTION AND TRANSFORMATION
4.1. Transport and distribution between media
4.1.1. Air
4.1.2. Water
4.1.3. Soil
4.1.3.1 Adsorption
4.1.4. Vegetation and wildlife
4.1.5. Entry into food chain
4.2. Biotransformation
4.2.1. Biodegradation and abiotic degradation
4.2.1.1 Plants
4.2.1.2 Soils
4.2.3. Bioaccumulation
4.3. Ultimate fate following use
5. ENVIRONMENTAL LEVELS AND HUMAN EXPOSURE
5.1. Environmental levels
5.1.1. Air
5.1.2. Water
5.1.3. Soil
5.2. General population exposure
5.2.1. Environmental sources
5.2.2. Food
5.3. Occupational exposure during manufacture, formulation
or use
6. KINETICS AND METABOLISM IN LABORATORY ANIMALS AND HUMANS
6.1. Absorption, distribution and excretion
6.1.1. Mouse
6.1.2. Rat
6.1.3. Human
6.2. Metabolic transformation
7. EFFECTS ON EXPERIMENTAL ANIMALS IN VITRO TEST SYSTEMS
7.1. Single exposure
7.1.1. Oral
7.1.2. Other routes
7.2. Short-term exposure
7.2.1. Oral
7.2.1.1 Dietary
7.2.1.2 Drinking-water
7.2.1.3 Intubation
7.2.2. Inhalational
7.2.3. Intraperitoneal
7.3. Long-term exposure
7.3.1. Oral
7.3.1.1 Mouse
7.3.1.2 Rat
7.3.1.3 Other species
7.3.2. Other routes
7.4. Skin and eye irritation; skin sensitisation
7.5. Reproduction, embryotoxicity and teratogenicity
7.5.1. Reproduction
7.5.2. Embryotoxicity and teratology
7.6. Mutagenicity and related end-points
7.6.1. DNA damage and repair
7.6.2. Mutation
7.6.3. Chromosome damage
7.6.4. Cell transformation
7.6.5. Other end-points
7.7. Carcinogenicity
7.7.1. Mouse
7.7.2. Rats
7.7.3. Other species
7.7.4. Carcinogenicity of amitrole in combination
with other agents
7.8. Other special studies
7.8.1. Cataractogenic activity in rabbits
7.8.2. Biochemical effects
7.9. Mechanisms of toxicity - mode of action
8. EFFECTS ON HUMANS
8.1. General population exposure
8.2. Occupational exposure
9. EFFECTS ON OTHER ORGANISMS IN THE LABORATORY AND FIELD
9.1. Laboratory experiments
9.1.1. Microorganisms
9.1.2. Aquatic organisms
9.1.2.1 Plants
9.1.2.2 Invertebrates
9.1.2.3 Vertebrates
9.1.3. Terrestrial organisms
9.1.3.1 Plants
9.1.3.2 Invertebrates
9.1.3.3 Birds
9.2. Field observations
9.2.1. Terrestrial organisms
9.2.1.1 Plants
9.2.1.2 Invertebrates
10. EVALUATION OF HUMAN HEALTH RISKS AND EFFECTS ON THE
ENVIRONMENT
10.1. Evaluation of human health risks
10.2. Evaluation of effects on the environment
11. CONCLUSIONS AND RECOMMENDATIONS FOR PROTECTION OF HUMAN HEALTH
AND THE ENVIRONMENT
11.1. Conclusions
11.2. Recommendations for protection of human health and the
environment
12. FURTHER RESEARCH
13. PREVIOUS EVALUATIONS BY NATIONAL AND INTERNATIONAL BODIES
REFERENCES
RESUME
RESUMEN
WHO TASK GROUP FOR ENVIRONMENTAL HEALTH
CRITERIA FOR AMITROLE
Members
Dr P.J. Abbott, Chemicals Safety Unit, Department of Health,
Housing and Community Services, Canberra, Australia
(Rapporteur)
Professor J.F. Borzelleca, School of Basic Health Sciences,
Department of Pharmacology, Richmond, Virginia, USAa
Professor V. Burgat-Sacaze, Ecole Nationale Vétérinaire, Toulouse,
France
Dr E.M. den Tonkellar, Toxicology Advisory Centre, National
Institute of Public Health and Environmental Protection,
Bilthoven, The Netherlands
Dr S. Dobson, Institute of Terrestrial Ecology, Monks Wood
Station, Abbots Ripton, Huntingdon, Cambridgeshire, United
Kingdom
Dr R. Fuchs, Department of Toxicology, Institute for Medical
Research and Occupational Health, University of Zagreb, Zagreb,
Croatia
Dr D. Kanungo, Division of Medical Toxicology, Central
Insecticides Laboratory, Department of Agriculture and
Cooperation, Directorate of Plant Protection, Quarantine and
Storage, Faridabad, Haryana, India
Professor M. Kessabi-Mimoun, Institut Agronomique et Vétérinaire
Hassan II, Rabat, Morocco
Professor M. Lotti, Università di Padova, Istituto di Medicina del
Lavoro, Padua, Italy (Chairman)
Professor A. Rico, Ecole Nationale Vétérinaire, Toulouse, France
(Vice-Chairman)
Observers
Mr C. Chelle, CFPI, Gennevilliers, France (GIFAP Representative)
Dr L. Diesing, Bayer AG, Institute of Toxicology and Agriculture,
Wuppertal, Germany (GIFAP Representative)
a Invited but unable to attend
Dr B. Krauskopf, Bayer AG, Leverkusen-Bayerwerk, Germany (GIFAP
Representative)
Dr Rouaud, Agrochemicals Division, CFPI, Gennevilliers, France
(GIFAP Representative)
Secretariat
Dr D. McGregor, Unit of Carcinogen Identification and Evaluation,
International Agency for Research on Cancer (IARC), Lyon,
France
Dr R. Plestina, International Programme on Chemical Safety, World
Health Organization, Geneva, Switzerland (Secretary)
NOTE TO READERS OF THE CRITERIA MONOGRAPHS
Every effort has been made to present information in the
criteria monographs as accurately as possible without unduly
delaying their publication. In the interest of all users of the
Environmental Health Criteria monographs, readers are kindly
requested to communicate any errors that may have occurred to the
Director of the International Programme on Chemical Safety, World
Health Organization, Geneva, Switzerland, in order that they may be
included in corrigenda.
* * *
A detailed data profile and a legal file can be obtained from
the International Register of Potentially Toxic Chemicals, Case
postale 356, 1219 Châtelaine, Geneva, Switzerland (Telephone No.
9799111).
* * *
This publication was made possible by grant number 5 U01
ES02617-14 from the National Institute of Environmental Health
Sciences, National Institutes of Health, USA.
ENVIRONMENTAL HEALTH CRITERIA FOR AMITROLE
A WHO Task Group on Environmental Health Criteria for Amitrole
met at the Ecole Nationale Vétérinaire, Toulouse, France, from 18 to
22 May 1993, the meeting being sponsored by the Direction générale
de la Santé, Ministère des Affaires sociales, de la Santé et de la
Ville, Paris. Professor A. Rico welcomed the participants on behalf
of the host institute. Dr R. Plestina, IPCS, opened the meeting and
welcomed the participants on behalf of Dr M. Mercier, Director of
the IPCS, and the three IPCS cooperating organizations
(UNEP/ILO/WHO).
The first draft was prepared by Dr P.J. Abbott, Department of
Health, Housing and Community Services, Canberra, Australia.
Extensive scientific comments were received following circulation of
the first draft to the IPCS contact points for Environmental Health
Criteria monographs and these comments were incorporated into the
second draft by the Secretariat. The Group reviewed and revised the
draft document and made an evaluation of the risks for human health
from exposure to amitrole.
Professor M. Lotti deserves special thanks for skilfully
chairing the meeting and for assistance to the Secretariat in
finalizing the monograph. Special thanks are also due to Professor
A. Rico for his technical support and exceptional hospitality.
Thanks are also due to Mrs A. Rico and the staff of the Ecole
Nationale Vétérinaire responsible for administrative aspects of the
meeting.
The fact that Bayer AG and Union Carbide made available to IPCS
and the Task Group proprietary toxicological information on their
products is gratefully acknowledged. This allowed the Task Group to
make its evaluation on a more complete data base.
Dr R. Plestina and Dr P.G. Jenkins, both members of the IPCS
Central Unit, were responsible for the overall scientific content
and technical editing, respectively, of this monograph. The efforts
of all who helped in the preparation and finalization of the
monograph are gratefully acknowledged.
ABBREVIATIONS
3-ATAL 3-(3-amino- s-triazole-1-yl)-2-aminopropionic acid
ACGIH American Conference of Governmental and Industrial
Hygienists
ADI acceptable daily intake
DAB 4-dimethylaminobenzene
DES diethylstilbestrol
DHPN N-bis(2-hydroxypropyl) nitrosamine
DIT diiodotyrosine
EC emulsifiable concentrate
GSH-Px glutathione peroxidase
HPLC high performance liquid chromatography
IC50 median immobilization concentration
MIT monoiodotyrosine
MTD maximum tolerated dose
NBU N-nitrosobutylurea
NOAEL no-observed-adverse-effect-level
NOEC no-observed-effect concentration
NOEL no-observed-effect level
OECD Organisation for Economic Co-operation and Development
PBI protein-bound iodine
PHS prostaglandin-H-synthetase
T3 L-triiodothyronine
T4 L-thyroxine
TC thin layer chromatography
TLV threshold limit value
TSH thyreostimulating hormone
TWA time-weighted average
WP wettable powder
1. SUMMARY
1.1 Identity, physical and chemical properties, and analytical
methods
Amitrole (3-amino-1,2,4-triazole) is a colourless, crystalline
powder. It is thermally stable and has a melting point of
156-159 °C. It is readily soluble in water and ethanol and only
sparingly soluble in organic solvents such as hexane and toluene.
Chemically, amitrole behaves as a typical aromatic amine as well as
an s-triazole. A wide range of analytical methods are available
for detection and quantification of amitrole in plants, soil, water,
air and urine.
1.2 Sources of human and environmental exposure
Amitrole does not occur naturally. It is manufactured by the
condensation of formic acid with aminoguanidine bicarbonate in an
inert solvent at 100-200 °C. Amitrole is used as a herbicide with a
wide spectrum of activity and appears to act by inhibiting the
formation of chlorophyll. It is commonly used around orchard trees,
on fallow land, along roadsides and railway lines, or for pond weed
control.
1.3 Environmental transport, distribution and
transformation
Owing to its low vapour pressure, amitrole does not enter the
atmosphere. It is readily soluble in water with a photodegradation
half-life in distilled water of more than one year.
Photo-degradation does occur in the presence of the photosensitizer
humic acid potassium salt, reducing the half-life to 7.5 h.
Amitrole is adsorbed to soil particles and organic matter by
proton association. The binding is reversible and not strong, even
in favourable acid conditions. Measured n-octanol/water partition
coefficient values classify amitrole as "highly mobile" in soils of
pH > 5 and "medium to highly mobile" at lower pH. There is
considerable variation in leaching of the parent compound through
experimental soil columns. Generally, movement is most readily seen
in sand; increasing the organic matter content reduces mobility.
Degradation in soils is usually fairly rapid but variable with
soil type and temperature. Bacteria capable of degrading amitrole
have been isolated. The herbicide can act as sole nitrogen source,
but not also as sole carbon source, for the bacteria. Microbial
degradation is probably the major route of amitrole breakdown;
little or no breakdown has been recorded in studies with sterilized
soil. However, abiotic mechanisms, including the action of free
radicals, have also been proposed as a means of degradation.
Laboratory studies have indicated degradation to CO2 with a
half-life of between 2 and 30 days. A single field study suggests
that the degradation may take longer at lower temperatures and
different soil moisture levels; the half-life was about 100 days in
a test clay.
Although the parent compound leaches through some soils,
degradation products are tightly bound to soil. Since amitrole is
degraded rapidly in soil, the high leaching potential of the
herbicide does not seem to be realized in practice. Occasional
damage to trees reported during the early usage of amitrole has not
been a regular feature of its use.
When applied to vegetation, amitrole is absorbed through the
foliage and can be translocated throughout the plant. It is also
absorbed through roots and transported in the xylem to shoot tips
within a few days.
High water solubility, a very low octanol-water partition
coefficient and non-persistence in animals means that there is no
possibility for bioaccumulation of amitrole or transport through
food chains.
1.4 Environmental levels and human exposure
Particulates containing amitrole may be released from
production plants; atmospheric levels of 0 to 100 mg/m3 have been
measured close to one plant.
The use of amitrole in waterways and watersheds has led to
transitory water concentrations of up to 150 µg/litre.
Concentrations fall rapidly to non-detectable (<2 µg/litre) levels
in running water within 2 h. Application to ponds gave an initial
water concentration of 1.3 mg/litre falling to 80 µg/litre after 27
weeks. Close to a production plant, river concentrations ranged from
0.5 to 2 mg/litre.
No residues of amitrole have been detected in food following
recommended use. Spraying of ground cover around fruit trees did not
lead to residues in apples. Wild growing fruit in the vicinity of
control areas can develop residues.
There have been no reports of amitrole in drinking-water.
1.5 Kinetics and metabolism in laboratory animals and humans
Following oral administration, amitrole is readily absorbed
from the gastrointestinal tract of mammals. It is rapidly excreted
from the body, mainly as the parent compound. The main route of
excretion in humans and laboratory animals is via the urine, and the
majority of excretion takes place during the first 24 h. Metabolic
transformation in mammals produces two minor metabolites detectable
in the urine of experimental animals. When an amitrole aerosol is
inhaled, a similar rapid excretion via the urine takes place.
1.6 Effects on experimental animals and in vitro test
systems
Amitrole had low acute toxicity when tested in several species
and by various routes of administration (LD50 values were always
higher than 2500 mg/kg body weight). It was found to affect the
thyroid after single, short-term and long-term exposures. Amitrole
is goitrogenic; it causes thyroid hypertrophy and hyperplasia,
depletion of colloid and increased vascularity. In long-term
experiments these changes precede the development of thyroid
neoplasia in rats.
The carcinogenic effect of amitrole on the thyroid is thought
to be related to the continuous stimulation of the gland by
increased thyroid stimulating hormone (TSH) levels, which are caused
by the interference of amitrole with thyroid hormone synthesis.
Equivocal results have been reported in some studies on the
genotoxic potential of amitrole. In carcinogenicity testing in rats,
amitrole did not induce tumours in organs other than the thyroid.
However, high doses of amitrole caused liver tumours in mice.
Several criteria have been used to assess the early effects of
amitrole on the thyroid. The lowest no-observed-adverse-effect level
(NAOEL) derived from these studies was 2 mg/kg in the diet of rats
and was assessed on the basis of thyroid hyperplasia.
1.7 Effects on humans
A single case of contact dermatitis due to amitrole has been
reported. Amitrole did not cause toxic effects when ingested at a
dose of 20 mg/kg. In a controlled experiment, 100 mg was found to
inhibit iodine uptake by the thyroid at 24 h. Weed control operators
exposed dermally to approximately 340 mg amitrole per day for 10
days exhibited no changes in thyroid function.
1.8 Effects on other organisms in the laboratory and field
Several studies on the growth of cyanobacteria (blue-green
algae) have shown no effect of amitrole at concentrations at or
below 4 mg/litre. No consistent adverse effects on nitrogen fixation
have been reported. Bacteria from soil were unaffected by
concentrations of 20 mg/litre medium in the case of nitrogen-fixing
Rhizobium and 150 mg/kg in the case of cellulolytic bacteria.
There were no effects on nitrification or soil respiration at 100 mg
a.i./kg dry soil, 5 times the maximum recommended application rate.
Reduced nodulation in sub-clover was reported at concentrations of
up to 20 mg/litre.
Various unicellular algae have been tested for
growth-inhibiting effects. At 0.2 - 0.5 mg amitrole/litre, the
growth inhibition of Selenastrum was the most sensitive reported
effect.
Most aquatic invertebrates show high tolerance to technical
amitrole: LC50 values were > 10 mg/litre for all organisms other
than the water flea Daphnia magna, where the acute 48-h EC50
(immobilization) was 1.5 mg/litre. Fish and amphibian larvae are
also tolerant to amitrole with LC50 values above 40 mg/litre.
Longer-term studies indicated that young rainbow trout survive an
amitrole concentration of 25 mg/litre for 21 days.
Two earthworm species (Eisenia foetida and Allolobophora
caliginosa) were unaffected by amitrole (SP50) at 1000 mg/kg
soil and Amitrole-T at 100 mg/kg soil, respectively. Carabid beetles
were unaffected after direct spraying with amitrole at rates
equivalent to 30 kg/ha. Effects on nematodes only occurred at high
concentrations of amitrole (the LC50 was 184 mg/kg).
Amitrole was reported to be non-hazardous to bees in field
trials. Amitrole has low toxicity to birds, all reported dietary
LC50 values being above 5000 mg/kg per diet. Acute oral dosing
killed no mallard ducks at 2000 mg/kg body weight.
2. IDENTITY, PHYSICAL AND CHEMICAL PROPERTIES, AND ANALYTICAL
METHODS
2.1 Identity
Common name: Amitrole
Chemical formula: C2H4N4
Relative molecular mass: 84.08
CAS chemical names: 1 H-1,2,4-triazol-3-amine (9C1)
3-amino- s-triazole (8CI)
IUPAC names: 1 H-1,2,4-triazol-3-ylamine
3-amino-1 H-1,2,4-triazole
3-amino- s-triazole
CAS registry number: 61-82-5
RTECS registry number: XZ3850000
Common synonyms: aminotriazole; 2-aminotriazole;
3-aminotriazole; 3-amino-1,2,4-
triazole; 2-amino-1,3,4-triazole;
3-amino-1H-1,2,4-triazole; AT;
3AT; ATA; 3,A-T; ATZ; AT-90;
triazolamine; 1,2,4-triazol-3-amine;
5-amino-1H-1,2,4-triazole.
Common trade names: Amerol; Aminotriazole Weedkiller
90; Aminotriazol Spritzpulver;
Amitril; Amitril T.L.; Amitrol;
Amitrol 90; Amitrol Plus;
Amitrol-T; Amizine; Amizol;
Amizol DP; Amizol F; AT Liquid;
Azaplant; Azolan; Azole; Azaplant
Kombi; Campaprim A1544; Cytrol;
Cytrole; Destraclol; Diurol. 5030;
Domatol; Domatol 88; Elmasil;
Emisol; Emisol 50; Emosol F; ENT
25445; Exit; Fenamine; Fenavar;
Fyrbar; Kleer-Lot; Lancer;
Nu-Zinole-AA; Orga 414; Preceed;
Radoxone TL; Ramizol; Sapherb;
Solution Concentree T271; Ustinex;
Vorox; Vorox AA; Vorox AS;
Weedar ADS; Weedar AT; Weedazin;
Weedazin Arginit; Weedazol;
Weedazol GP2; Weedazol Super;
Weedex Granulat; Weedoclor; X-All
Liquid.
Technical grade amitrole contains a minimum of 95% active
ingredient and is formulated as a solution of 250 g/litre in water,
usually with an equimolar concentration of ammonium thiocyanate, or
as a 400 g/kg wettable powder, usually in combination with other
herbicides.
The major impurities are 3-(N-formylamino)-1,2,4-triazole,
4 H-1,2,4-triazole-3,4-diamine, and
4 H-1,2,4-triazole-3,5-diamine.
2.2 Physical and chemical properties
Some of the physical and chemical properties of amitrole are
shown in Table 1.
Amitrole is readily soluble in water, methanol, ethanol and
chloroform, sparingly soluble in ethyl acetate, and insoluble in
hydrocarbons, acetone and ether. It forms salts with most acids or
bases and is a powerful chelating agent. It is corrosive to
aluminium, copper and iron. Chemically, amitrole behaves as an
s-triazole and also as an aromatic amine, and hence will diazotize
and couple several dyes.
2.3 Conversion factors:
1 mg/kg = 3.43 mg/m3 1 mg/m3 = 0.29 mg/kg
Table 1. Some physical and chemical properties of amitrole
Physical state crystalline
Colour colourless
Taste bitter
Odour none
Thermal stability stable at 20 °Ca
Hydrolytic stability (pH 4-9; 90 °C) stableb
Melting point 157-159 °Cc
Water solubility (25 °C) 280 g/litrec
Water solubility (53 °C) 500 g/litred
Ethanol solubility (75 °C) 260 g/litred
Solubility in n-hexane (20 °C) < 0.1 g/litred
Solubility in dichloromethane (20 °C) 0.1-1 g/litred
Solubility in 2-propane 20-50 g/litred
Solubility in toluene (20 °C) <0.1 g/litred
Vapour pressure (20 °C) 55 nPac
Octanol/water partition coefficient (21 °C)
(log Pow) -0.969e
a Klusacek & Krasemann (1986)
b Krohn (1982)
c Worthing & Hance (1991)
d Personal communication from Bayer AG to the IPCS (1993)
e Hazleton Laboratories, USA Report HLA-6001-187
2.4 Analytical methods
2.4.1 Plants
Early methods for the detection of amitrole by paper
chromatography or for its quantitative determination by
spectrophotometry involved extraction by ethanol or water,
diazotization of the 3-amino group and, finally, coupling with
either phenol in 20% HCl (Aldrich & McLane, 1957),
N-(1-naphthyl)ethylenediamine dihydrochloride (Storherr & Burke,
1961), H-acid (8-amino-1-naphthol-3,6-disulfonic acid, monosodium
salt) (Racusen, 1958; Herrett & Linck, 1961; Agrawal & Margoliash,
1970) or chromotropic acid (Green & Feinstein, 1957). This technique
has been used for residue analysis in plants (Aldrich & McLane,
1957; Herrett & Linck, 1961), and vegetable crops (Storherr & Burke,
1961). The detection limit was found by Aldrich & McLane (1957) to
be approximately 0.1 µg/spot. The method outlined by Storherr &
Burke (1961) is sensitive to 0.025 mg/kg. Recovery was described by
Herrett & Linck (1961) to be close to 100%. Storherr & Onley (1962)
found that dry-packed cellulose column chromatography was preferable
to paper chromatography for separation of amitrole from some crops.
Several gas chromatographic methods have been developed to
determine amitrole residues in plants (Jarczyk, 1982a, 1985; Jarczyk
& Möllhoff, 1988). The principle of all these methods is similar.
After extraction with an ethanol-water mixture, acetylation with
acetic anhydride (conversion of amitrole to the monoacetyl
derivative) and a clean-up step by gel chromatography, the residue
is dissolved in acetone or ethanol and determined by a gas
chromatograph equipped with a nitrogen-phosphorus detector.
Weber (1988) developed a method for the determination of
amitrole in plant material by high performance liquid chromatography
(HPLC). Amitrole was extracted with an acetone-water mixture and the
water phase was extracted with dichloromethane to remove lipophilic
compounds. After a further clean-up step with column chromatography
on a cation exchange resin and on aluminium oxide, the residues were
determined by HPLC with ion pairing reagent and electrochemical
detection. In plants the detection limit was 0.01 mg/kg and the
recovery was between 91 and 99% in the range 0.01-1.0 mg/kg.
The Codex Committee on Pesticide Residues has recommended the
methods of Lokke (1980) and Van der Poll et al. (1988).
The method of Lokke (1980) uses ion-pair HPLC, which in
potatoes or fodder beets had a limit of detection between 0.005 and
0.01 mg/kg.
The method of Van der Poll et al. (1988) is capable of
determining amitrole in plant tissues and sandy soils by capillary
gas chromatography with an alkali flame ionization detector. Samples
are extracted with ethanol, absorbed on resin and desorbed with
ammonia. After acetylation with acetic anhydride and clean-up with a
SEP-PAK silica cartridge, the residue is determined by gas
chromatography (GC). The limit of detection is 0.02 mg/kg and
average recoveries are 76-81% in the range from 0.05 to 0.2 mg/kg.
2.4.2 Soil
An early method for the determination of residues in soil was
developed by Sund (1956) which involved extraction with water
followed by colour reaction with nitroprusside in alkaline
solutions.
Groves & Chough (1971) developed an improved procedure for the
extraction of amitrole from soil using concentrated ammonium
hydroxide and glycol (1:4). Pribyl et al. (1978) investigated the
extraction of amitrole from soils and its identification and
quantitation by photometry and thin layer chromatography (TLC). The
limit of detection was 0.05 mg/kg. They proposed analysis by TLC
after reaction with 5-dimethylaminonaphthalene-1-sulfonyl chloride
(dansylation), in preference to HPLC. Lokke (1980) suggested that
HPLC separation could be used if preceded by clean-up on a polyamide
column. Both the GC method (Jarczyk, 1985; Jarczyk & Möllhoff, 1988)
and the HPLC method (Weber, 1988) described in section 2.4.1 for
plants are also suitable for the determination of amitrole residues
in soil.
2.4.3 Water
Marston et al. (1968) and Demint et al. (1970) have used cation
ion-exchange column chromatography to extract amitrole from
contaminated creek and canal waters. This is followed by
diazotization and coupling as described by Storherr & Burke (1961).
Alary et al. (1984) have modified these methods to achieve a
spectrophotometric determination of amitrole in waste water in the
vicinity of production plants in the presence of interfering amino
compounds.
A more recent capillary gas-liquid chromatographic method for
determining amitrole in ground water and drinking-water, using an
alkali flame ionisation detector, has been described, the reported
limit of detection being 0.1 µg/litre (Van der Poll et al., 1988).
Legrand et al. (1991) formed a nitroso derivative of amitrole
concentrated from surface and ground waters prior to HPLC analysis.
The nitroso derivative showed an absorption maximum in the near UV
spectrum. Aqueous solutions of amitrole in the range of
0.25-0.50 µg/litre were measurable, and the recoveries were 70 ± 8%
(n = 11). The limit of determination was 0.1 µg/litre.
Pachinger et al. (1992) developed an HPLC analytical method
with amperometric detection for the determination of amitrole
without derivatization in drinking-water and ground water. Detection
limits were 1 mg/litre for directly injected samples and
0.1 µg/litre following an evaporation step to concentrate the
samples. Recoveries were close to 100%.
Both the GC method (Jarczyk, 1985; Jarczyk & Möllhoff, 1988)
and the HPLC method (Weber, 1988) described in section 2.4.1 for
plants are also suitable for the determination of amitrole residues
in water.
An immunochemical approach to the detection of amitrole has
been recently described by Jung et al. (1991). Development of this
rapid and sensitive method is likely to lead to a very effective
method for detecting amitrole in waterways.
2.4.4 Formulations
Ashworth et al. (1980) described a potentiometric precipitation
titration method using silver nitrate and silver/silver chloride or
silver/mercurous sulfate electrode. This method can be used for the
determination of amitrole in its formulations or in the presence of
triazines, substituted urea herbicides or plant growth regulators
such as bromacil and ammonium thiocyanate. Another method for the
determination of amitrole in its formulations has been described by
Gentry et al. (1984). This involves dissolving or extracting the
sample with dimethylformamide, acidifying by adding 0.5 N HCl and
back-titrating the excess acid with 0.5 N sodium hydroxide.
Jacques (1984) has described a simple GC method for the
detection and quantification of amitrole in technical and formulated
products.
A TLC method for the routine identification of amitrole in
pesticide mixtures has been developed by Ebing (1972).
2.4.5 Air
Alary et al. (1984) have described a method for the analysis of
air samples collected on glass-fibre filters followed by
diazotization and coupling to produce a colour reaction. The
detection limit was not reported.
2.4.6 Urine
In order to assay amitrole in urine samples, Geldmacher-von
Mallinckrodt & Schmidt (1970) separated the amitrole by paper
chromatography using phenol saturated with water, or a mixture of
n-butanol:water (15:1) and propionic acid:water (7:6), and
identified amitrole by spraying with a solution of
p-dimethyl-aminobenzaldehyde in acetic acid or hydrochloric acid.
In a more recent paper by Archer (1984), a proposed method for
biological monitoring of urine samples used HPLC separation with a
visible light detector following diazotization and coupling. The
detection limit was 200 µg/litre.
3. SOURCES OF HUMAN AND ENVIRONMENTAL EXPOSURE
3.1 Natural occurrence
Amitrole does not occur naturally.
3.2 Anthropogenic sources
3.2.1 Production levels and processes
The synthesis of amitrole was first reported by Thiele &
Manchot in 1898 and involved the reaction of aminoguanidine with
formic acid (Carter, 1975). The current industrial production
process, described by Allen & Bell (1946), involves the same
reaction, in which an aminoguanidine salt is heated to 100-120 °C
with formic acid in an inert solvent (Carter, 1975; Sittig, 1985).
Amitrole is currently manufactured or formulated in several
countries. Its use has declined, particularly in the USA. However,
in spite of some recent replacements, amitrole remains a widely used
herbicide.
3.2.2 Uses
Amitrole is primarily used as a post-emergent non-selective
herbicide and has a very wide spectrum of activity against annual
and perennial broad leaf and grass type weeds. Its primary mode of
action is unknown but a prominent feature is its inhibition of the
formation of chlorophyll, and weeds initially change colour to
white, brown or red, and subsequently die (Carter, 1975). This
herbicidal activity is enhanced by the addition of ammonium
thiocyanate as a synergist. Amitrole can be used alone as a
concentrated solution in water or as a wettable powder in
combination with other herbicides. It is primarily used as a
herbicide and as a brush killer. It is also used as a non-selective
pre-emergent herbicide on fallow land before planting kale, maize,
oilseed rape, potatoes and wheat, and in other non-crop situations
(Worthing & Hance, 1991). It is also used along roadsides and
railway lines to control weeds. Approved uses of amitrole on soil
are either for non-crop land prior to sowing, or for inter-row weed
control in tree and vine crops, where contact with food plants is
avoided. Amitrole is also used for the control of pond weeds and is
an especially effective herbicide in the control of water hyacinth
(Eichhornia crassipes).
Amitrole has also been used as a cotton defoliant in some
countries (Hassall, 1969).
4. ENVIRONMENTAL TRANSPORT, DISTRIBUTION AND TRANSFORMATION
4.1 Transport and distribution between media
4.1.1 Air
The very low vapour pressure of amitrole (Table 1) means that
it will not enter the atmosphere.
4.1.2 Water
Amitrole is readily soluble in water (280 g/litre at 25 °C) and
has a half-life of more than one year at 22 °C and pH 4-9 (Worthing
& Hance, 1991). Although no direct photolysis occurred in doubly
distilled water, the photodegradation rate increased in the presence
of humic acid, potassium salt (100 mg/litre), a natural
"photosensitizer", resulting in a half life of 7.5 h (Jensen-Korte
et al., 1987).
4.1.3 Soil
4.1.3.1 Adsorption
Amitrole is adsorbed to soil particles and organic matter by
proton association. The adsorbed aminotriazolium cation will enter
into cationic exchange reactions (Nearpass, 1969). Binding is
strongly pH dependent, and the cation is adsorbed to a greater
extent in acid conditions. The aminotriazolium cation is bound more
strongly than sodium but is displaced by calcium ions. The binding
is reversible and not strong, even in favourable acid conditions.
The binding capacity of soils at pH 5 or more is limited (Nearpass,
1970). Anderson & Hellpointner (1989) determined the Koc values
for amitrole in four soils i.e. silty clay, sandy loam, sand and
silt, to be 112, 30, 20 and 52, respectively. Adsorption increased
at lower pHs; adjustment of pH to a constant 4.5 resulted in Koc
values ranging from 77 to 356. The authors classified amitrole as
highly mobile in the soils at their equilibrium pH values of 5.6 to
7.4 and medium to highly mobile with the pH adjusted from 4.2 to
4.5.
There is considerable variation in the literature, both old and
recent, in reported adsorption and leachability of amitrole. Sund
(1956) described adsorption to soil as strong. He demonstrated that
amitrole could be efficiently removed from aqueous solution with a
resin cation exchanger and argued that soil would also bind the
compound efficiently. A correlation between the base exchange
capacity of soil and binding of amitrole was postulated. This agrees
with the theoretical and experimental work of Nearpass (1969, 1970),
although the latter author does not support the strength of
adsorption proposed by Sund (1956). Day et al. (1961) investigated
leaching of amitrole through 400-g, 4-cm diameter columns of three
different soils from a citrus growing area of California following
occasional reports of damage to trees after application of high
rates of amitrole for the control of perennial weeds. Amitrole moved
readily with the leaching water for all soil types (two sandy loams
and one silt loam) and most readily through quartz sand. Zandvoort
et al. (1981) supported this conclusion, suggesting that the high
water solubility of amitrole could result in leaching from sandy
soils. Weller (1987) investigated leaching of amitrole through
27-cm, 5-cm diameter columns of two soils, a sandy "standard soil
2.1" and a second soil with substantially higher organic content.
Immediately after incorporation of the 14C-amitrole to give 2 mg
on the surface area of the column, leaching with deionized water
began, 393 ml being pumped onto the soil column over 2 days. The
leachate was collected in two fractions: 175-191 ml and 185-200 ml.
Duplicate experiments showed 24 and 31% of the initial radioactivity
in the leachate (entirely in fraction II) in the sandy soil, with
11%, 16% and 46%, respectively, remaining in the upper, middle and
lower third of the soil column. The second soil leached markedly
less of the added radioactivity (1.4 and 1.8% for the duplicate
columns); this also appeared in fraction II. The radioactivity in
the leachate was unchanged amitrole.
Since amitrole is degraded rapidly in soil (section 4.2.1), the
high potential of amitrole to leach through sandy soils does not
seem to be realized in practice. The occasional damage to trees
reported in the study by Day et al. (1961) has not been a regular
feature of the use of amitrole. Degradation products of amitrole do
not leach significantly through soil (section 4.2.1).
4.1.4 Vegetation and wildlife
When applied directly to vegetation as a herbicide, amitrole is
absorbed through the foliage and can be translocated throughout the
plant. Translocation occurs in the photosynthetic stream and is
dependent on light. When applied to soil, amitrole can be adsorbed
through the roots and transported in the xylem, within a few days,
to the tips of the shoots (Carter, 1975).
4.1.5 Entry into food chain
Amitrole is not to be used on food crops and therefore food
residues should not occur. Grazing animals could consume amitrole as
surface residues on vegetation after application or as residues
within the plant. Amitrole is not persistent in animals and would
not be expected to pass through the food chain.
4.2 Biotransformation
4.2.1 Biodegradation and abiotic degradation
4.2.1.1 Plants
Racusen (1958) reported the first comprehensive studies of
amitrole metabolism in plants. Two major metabolites were isolated,
neither of which were as phytotoxic as amitrole. These results were
supported by studies by Carter & Naylor (1960). One metabolite was
identified as the product of the reaction of amitrole with serine,
namely, 3-(3-amino- s-triazole-1-yl)-2-aminopropionic acid
(3-ATAL). Formation of 3-ATAL is considered to represent
detoxification since ammonium thiocyanate, which synergizes the
action of amitrole, inhibits the formation of 3-ATAL (Smith et al.
1969). Other products of amitrole metabolism in plants have not been
identified. Fang et al. (1967) found that metabolism of amitrole in
leaves was exponential, with half-lives in sugar beet, corn and bean
leaves being 18.7, 28.0 and 23.2 h, respectively. A review of the
degradation of amitrole in plants has been presented by Carter
(1975).
The soluble metabolites of [3,5-14C]-amitrole in apples were
examined by Schneider et al. (1992) following soil application.
Significant proportions of the radioactivity were found as bound
residues, but 69-90% were extractable with acetonitrile. In addition
to 3-ATAL, 3-(1,2,4-triazole-1-yl)-2-aminopropionic acid
(3-aminotriazolylalanine) was also identified, in both the free form
and as conjugates. This was the major metabolite in apple cell
cultures treated with amitrole (Stock et al., 1991).
4.2.1.2 Soils
There is general agreement that degradation of amitrole in soil
is usually fairly rapid and variable with soil type and temperature.
However, there is no clear consensus on the relative roles of biotic
and abiotic processes in the breakdown of the compound.
Day et al. (1961) measured amitrole colorimetrically in 55
different soils of 5 main types from California and estimated the
depletion after 2 weeks of incubation. The results were very
variable, 26 soils having no measurable amitrole after 2 weeks, 6
soils showing traces and the remaining 23 soils having higher
quantities, in some cases comparable to initial levels. Four soils
had more than half of the original amitrole after the 2-week
incubation. It was not possible to correlate depletion of amitrole
to soil type. The authors classified the soils according to general
type and ranked them in terms of "heaviness"; the four soils
retaining most amitrole ranked 7, 23, 30 and 54 in the list. There
was a geographical correlation with reported incidents of non-target
effects of the herbicide. Some specific characteristic of a variety
of soils from a single location had led to movement of the herbicide
and its retention longer than in apparently comparable soils
elsewhere. Decomposition rates in steam-sterilized soils were much
lower than in unsterilized soils, which led the authors to conclude
that breakdown was principally due to microorganisms. Decomposition
was optimal at temperatures between 20 and 30 °C and at medium to
high soil moisture content. Breakdown was not well correlated with
soil classification, texture, base-exchanged capacity or adsorption
capacity for amitrole. Differences in microbial populations were
cited as the most likely explanation for the variation.
Kaufman et al. (1968) also found that sterilization of soil
reduced the breakdown of amitrole. Within 20 days, 69% of the
radioactivity of 14C-labelled amitrole was released as 14CO2
in unsterilized soil. Soil treated with sodium azide or ethylene
oxide released 46% and 35%, respectively, whilst autoclaved soil
released only 25%. Reinoculation of soil with microorganisms
isolated from the original soil failed to restore the capacity to
degrade amitrole. Amending the soil with other organic compounds
reduced amitrole degradation. The authors concluded that degradation
of amitrole was largely a chemical process and that microbial action
was indirect. Free radicals (such as HO.) were proposed as agents
for oxidation of the amitrole nucleus. Plimmer et al. (1967) studied
the degradation of amitrole by free-radical generating systems. They
demonstrated that riboflavin (and light) or an ascorbate-copper
reagent (Fenton's reagent) promotes oxidation of amitrole, resulting
in ring cleavage, loss of CO2 and production of urea, cyanamide
and possibly molecular nitrogen. Riepma (1962) observed a lag-phase
which he considered typical of microbial breakdown. Carter (1975)
concluded that "whatever the mechanism, triazole ring opening occurs
rapidly in soils and the resulting products ... should be readily
metabolized by soil microorganisms".
Campacci et al. (1977) reported the isolation of bacteria
capable of degrading amitrole, strengthening the argument for
microbial involvement. Only one of three media tested succeeded in
growing organisms that could degrade amitrole. Of 36 isolates from
this culture, 10 were found to be capable of degrading amitrole.
Nine of these were gram-positive rods (Bacillus spp. and
Corynebacterium spp.) and one was identified as a Pseudomonas
sp. The growth of these bacteria was roughly proportional to
amitrole concentration up to 256 mg/litre. The organisms could
degrade amitrole as sole nitrogen source but not also as sole carbon
source; the medium was enriched with sucrose. This explained
previous failures to isolate organisms capable of degrading the
herbicide.
Various studies have quantified the degradation of amitrole in
soil. Scholz (1988) observed the release of 48% of applied
radioactivity (14C-amitrole) as 14CO2 after 5 days. In
degradation studies in the laboratory, half-lives of between 2.4 and
9.6 days were observed in different soils. DT90 (the time required
for degradation of 90% of the amitrole) values were in the range of
13 to 22 days (LUFA, 1977; Jarczyk, 1982b,c,d). Hawkins et al.
(1982b) measured 70-80% degradation to CO2 in standard soil and
40-50% in English clay soil within 28 days. There was no release of
14CO2 from autoclaved soil. Hawkins et al. (1982a) measured
decomposition in the same English clay in the field. Here 53% of the
applied radioactivity remained after 112 days. The slower rate of
breakdown in the field was ascribed to the temperature and soil
moisture content. Schneider et al. (1992) suggested that amitrole
can be deaminated in soil to give triazole.
A study by Weller (1987) examined the leaching of "aged"
residues of amitrole. Soils, with 14C-amitrole incorporated as
described in section 4.1.3.1, were incubated for 30 and 92 days, in
duplicate experiments, and then used in leaching tests as for the
initial soils. For both the "standard soil 2.1" and the second soil,
between 50 and 73% of initial radioactivity was lost as 14CO2
during incubation. Of the remaining radioactive material, negligible
amounts leached through the soil column in tests after 30 and 92
days. Almost all of the activity remained in the upper third of the
soil column. After 30 days 4% or less of the activity was unchanged
amitrole. The breakdown products of amitrole (not characterized
except for traces of urea) were tightly bound to the soil and were
not leachable or easily extractable.
4.2.3 Bioaccumulation
Flow-through studies on fish using 14C-amitrole indicated
that the bioaccumulation of amitrole in bluegill sunfish (Lepomis
macrochirus) and in channel catfish (Ictalurus punctatus),
exposed to 1 mg/litre, was only slight after 21 days of exposure
(approximately 1.7-3.0 times the amitrole concentration in the
water). When the fish were returned to untreated water, the amitrole
concentration in their organs fell rapidly (Iwan et al., 1978).
Bioaccumulation of amitrole by aquatic organisms would not be
expected because of its high water solubility and very low
octanol-water partition coefficient (Table 1).
4.3 Ultimate fate following use
MacCarthy & Djebbar (1986) described a method using chemically
modified peat to decontaminate eluant from chemical production
plants before it enters major waterways. When converted to a
granular product suitable for column chromatography, the peat can
act as an efficient ion-exchange material for the removal of
amitrole and other basic chemicals.
Amitrole is resistant to hydrolysis and the action of oxidizing
agents. Burning the compound with polyethylene is reported to result
in > 99% decomposition (Sittig, 1985).
5. ENVIRONMENTAL LEVELS AND HUMAN EXPOSURE
5.1 Environmental levels
5.1.1 Air
Amitrole-containing particles are released from the stack of
production plants during dry crushing and, to a lesser extent,
bagging operations. Atmospheric levels in the range of 0 to
100 µg/m3 were measured in the vicinity of such a plant (Alary
et al., 1984). Severe chlorosis and defoliation was noted following
atmospheric fallout in the vicinity of the plant.
5.1.2 Water
Grzenda et al. (1966) studied the persistence of amitrole and
three other herbicides in pond water following an aquatic weed
control programme. The initial level on day one of 1.34 mg/kg
decreased gradually to 1.03 mg/kg on day 11, 0.73 mg/kg on day 25,
0.49 mg/kg at 9.5 weeks and 0.08 mg/kg at 27 weeks.
In a study by Marston et al. (1968) in which 100 acres of a
watershed in Oregon was sprayed, the levels of amitrole in water
samples were measured on the downstream edge of the sprayed area. A
maximum concentration of 155 µg/litre was found 30 min after
application began, but this decreased to 26 µg/litre by the end of
the application. No amitrole could be detected 6 days after
spraying. The detection limit was 2 µg/litre.
Demint et al. (1970) measured the amitrole concentration in two
flowing water canals following treatment of a single ditchbank of
each canal with amitrole at the normal treatment rate. Samples taken
at stations up to 7.2 km downstream indicated rapid decreases in
amitrole levels following passage of the initial amitrole-bearing
water, the levels having declined to 1 µg/litre within 2 h. In a
preliminary environmental survey conducted in 1984 in Japan,
amitrole was not detected (detection limit 4 µg/litre) in any of 24
water samples nor was it detected in any of the 24 bottom sediments,
the detection limit being 5-20 µg/kg (Environment Agency Japan,
1987).
Alary et al. (1984) measured the level of amitrole in water
samples collected in a river downstream from the discharge of an
aeration pond in the vicinity of a production plant. The levels were
in the range of 0.5 to 2 mg/litre while the concentration in the
water of the aeration pond was in the range of 50 to 200 mg/litre.
Legrand et al. (1991) tried to detect 38 compounds including
amitrole in different areas of France (13 sampling points) with a
detection limit of 0.1 µg/litre, but no amitrole was found.
5.1.3 Soil
As discussed in chapter 4, amitrole, when applied to soil, is
readily degraded or adsorbed to the soil particles.
5.2 General population exposure
5.2.1 Environmental sources
No exposure would be expected from environmental sources.
5.2.2 Food
Amitrole is not to be used on food crops, and food residues
should therefore not occur. Using a limit of determination of
0.05 mg/kg, amitrole was not detectable in a wide range of food
crops (Duggan et al., 1966, 1967; Corneliussen, 1969, 1970). This
was confirmed by several studies (Bayer AG, 1993a,b).
Experimental studies in West Virginia, USA, indicated that
residues of amitrole on whole apples could not be detected 3 months
after ground cover application, but could be detected when either
fruit or foliage or both were directly treated with amitrole
(Schubert, 1964). The analyses were conducted using the method of
Storherr & Burke (1961) with a detection level of 0.025 mg/kg.
Similarly, residue trials conducted in Tasmania and New South
Wales on apples did not reveal amitrole at a detection limit of
0.01 mg/kg following ground cover application (Moore, 1968, 1969,
1970). A slight modification of the method of Storherr & Burke
(1961) was used.
In one study, residues of amitrole were found in blackberries
growing very near a railway line that was sprayed by amitrole in the
normal way by the railway authorities. Thirteen days after spraying
at a dose 3,5 kg a.i./ha, blackberries were picked close to the
railway at two different locations. The mean residues found at the
two locations were 0.67 (0.2-1.4) mg/kg and 2.0 (0.1-3.8) mg/kg. The
places where the blackberries were picked was prohibited to the
general public. This study shows that spraying of amitrole on
blackberries results in considerable residues (Dornseiffen &
Verwaal, 1988).
5.3 Occupational exposure during manufacture, formulation or use
The potential for toxicity via the dermal or inhalational
routes appears to be low. A threshold limit value (TLV) of
0.2 mg/m3, as an 8-h time-weighted average (TWA), has been set for
amitrole by the American Conference of Governmental & Industrial
Hygienists (ACGIH, 1991-1992). Amitrole is a mild skin and eye
irritant.
6. KINETICS AND METABOLISM IN LABORATORY ANIMALS AND HUMANS
6.1 Absorption, distribution and excretion
6.1.1 Mouse
The distribution of [5-14C]-radiolabelled amitrole has been
examined in non-pregnant C57BL strain female mice (Tjalve, 1975) and
in the fetuses of pregnant NMRI strain mice (Tjalve, 1974). In each
case, the mice received amitrole (5 µCi) either intravenously or
orally, and the distribution of radioactivity was determined by
whole-body autoradiography of the adult or fetus at intervals of
5 min to 5 days after administration. In the non-pregnant animals,
further analysis of the distribution of radioactivity was performed
by microautoradiography of the spleen and thymus, and by subcellular
fractionation of the liver, spleen and thymus. The highest
radioactivity was found in tissues with rapid cell turnover, e.g.,
bone marrow, spleen, thymus and gastrointestinal mucosa. Only a
moderate level of radioactivity was found in the thyroid. The level
of radioactivity in the tissues was the same whether the treatment
was intravenous or oral. In all cases, there was a significant
decrease over the 5-day period. Microautoradiography indicated
amitrole was located mostly in the cytoplasm. 14C-labelled
amitrole crossed the placental barrier and could be detected in
fetal tissues 4 and 8 h after administration to the dams by
intravenous injection or gavage.
Following intravenous administration of 14C-amitrole
(3.4 mg/kg body weight), adult ICR mice were killed at given
intervals (5 min, 30 min, 8 h and 24 h) and submitted to whole-body
autoradiography and microautoradiography. The liver had the highest
accumulation of radioactivity and two distribution patterns were
observed: a homogenous distribution up to 8 h following injection,
and a subsequent heterogenous one. Liver sections were extracted
with trichloroacetic acid and methanol, but considerable amounts of
radioactivity remained non-extractable. A microauto-radiography of
the liver 8 h after 14C-amitrole injection revealed that the
radioactivity was localized in the centrolobular areas (Fujii
et al., 1984).
6.1.2 Rat
Kinetic studies on amitrole in rats were performed by Fang
et al. (1964). Groups of Wistar rats were administered 1 mg
14C-amitrole by gavage and the distribution of radioactivity was
analysed at various time intervals between 30 min and 6 days. High
levels of radioactivity (70-95% of the administered radioactivity)
were found in the urine during the first 24 h, but only low levels
in the faeces, indicating rapid and almost complete absorption from
the gastrointestinal tract followed by rapid excretion. Tissue
levels were very low after 3 days, and significant amounts were
found only in the liver. In a second experiment (Fang et al., 1966),
14C-amitrole was administered at various dose levels (1-200 mg/kg
body weight). The average total radioactivity found in urine and
faeces (as a percentage of the administered dose) was comparable for
all the doses applied. The difference in average half-time for
clearing of radioactivity from various organs was considered to be
insignificant between dosages of 1 and 200 mg/kg. The fate of two
unidentified plant metabolites of amitrole, i.e. 14C-metabolite 1
and 14C-metabolite 3 (isolated from bean plants), was also
examined by Fang et al. (1966). Radioactivity from metabolite-1 was
excreted rapidly in the urine in the first 48 h and identified as
unchanged metabolite-1. Elimination of metabolite-3 was mainly in
the faeces. In a study by Grunow et al. (1975), 14C-amitrole was
administered to rats by gavage at a dose level of 50 mg/kg, and the
urine and faeces were examined over 3 days. The major route of
excretion of radioactivity was the urine, the majority of the
radioactivity being excreted in the first 24 h.
Two groups of five male and five female Sprague-Dawley rats
weighing 200-250 g were exposed (either nose only or whole body) to
atmospheres of 5-14C-amitrole (radiochemical purity > 97%) in
water aerosols at concentrations in air of 49.2 µg/litre
(2.6 µCi/litre) or 25.8 µg/litre (1.4 µCi/litre), respectively, for
1 h, and then observed for 120 h (MacDonald & Pullinger, 1976). The
particle size distribution of the aerosols was not reported. The
calculated elimination half-life of radioactivity was approximately
21 h for both exposures; approximately 75% of the radioactivity was
eliminated in the urine within 12 h.
6.1.3 Human
Urinary excretion of unchanged amitrole has been reported in a
woman who ingested approximately 20 mg/kg of the herbicide
(Geldmacher-von Mallinckrodt & Schmidt, 1970).
6.2 Metabolic transformation
The limited data available indicates that little metabolic
transformation of amitrole occurs in mammalian species. In the
mouse, tissue residues were identified by TLC as mainly unchanged
amitrole (84% of the detected radioactivity) when measured 8 h after
exposure (Tjalve, 1975). Similarly, paper chromatographic analysis
of rat liver residues following oral administration revealed
unchanged amitrole plus one unidentified metabolite (Fang et al.,
1964). In the urine of rats, the majority of the radioactivity was
also unchanged amitrole; one unidentified metabolite was isolated
which represented approximately 20% of the total radioactivity. The
liver was the site of the unidentified metabolite-1 formation and
the rate of elimination of this metabolite from liver and kidney was
much slower (Fang et al., 1964).
In a more extensive analysis of urinary metabolites in the rat
by Grunow et al. (1975), the major part of the radioactivity
identified by paper chromatography corresponded to unchanged
amitrole. Two urinary metabolites were identified as
3-amino-5-mercapto-1,2,4-triazole and
3-amino-1,2,4-triazolyl-(5)-mercapturic acid, which together
amounted to approximately 6% of the administered dose.
In a metabolic study (Turner & Gilbert, 1976), which was
supplementary to the inhalation exposure experiment and is described
in section 6.1.2 (MacDonald & Pullinger, 1976), it was found that
approximately 60% of the urinary radioactivity chromatographed on
silica gel 60 TLC in methanol: 880 ammonia (100: 1.5, s/s) as
amitrole, 15-20% remained at the origin and 5-8% migrated faster
than amitrole. Treatment with ß-glucuronidase had no effect upon
this TLC distribution.
7. EFFECTS ON EXPERIMENTAL ANIMALS AND IN VITRO TEST SYSTEMS
7.1 Single exposure
7.1.1 Oral
The acute oral toxicity data for amitrole when administered as
an aqueous suspension are presented in Table 2.
Table 2. Acute oral toxicity of amitrole
Species LD50 (mg/kg Reference
body weight)a
Rat > 4080 (m and f) Gaines et al. (1973)
> 4200 Seidenberg & Gee
24 600 (m) Bagdon et al.(1956)
> 10 000 Hecht (1954)
> 2500 Kimmerle (1968)
> 5000 (m) Thyssen (1974)
> 5000 (m) Heimann (1982)
Mouse 11 000 Hapke (1967)
14 700 (m) Fogleman (1954)
Cat > 5000 (m and f) Bagdon et al. (1956)
a m = males; f = females
In cats and dogs the general signs of toxicity were dyspnoea,
ataxia, and diarrhoea with vomiting. Coma and death appeared to be
associated with profound respiratory depression. Gastro-intestinal
irritation and haemorrhage were the only treatment-related findings.
The toxicity of a mixture of amitrole and ammonium thiocyanate
(1:1), referred to as Amitrol-T, appeared to be slightly higher than
that of amitrole itself, but was still very low. LD50 values
obtained following oral administration in rats were 3500 mg/kg and
10.5 ml/kg of the commercial product (DeProspo & Fogleman, 1973;
Field, 1979).
The possibility that amitrole might form a Schiff's base with
glucose was investigated by Shaffer et al. (1956). An
amitrole-glucose adduct was prepared and administered orally to rats
and mice (10 mg/kg), intraperitoneally to mice (10 mg/kg), and
intravenously to mice (1.6 mg/kg). There were no deaths or signs of
toxicity following treatment.
7.1.2 Other routes
The acute toxicity of amitrole by other routes of
administration is very low, as shown in Table 3.
Table 3. Acute, dermal, intraperitoneal and intravenous toxicity
of amitrole
Species Route LD50 (mg/kg bw) Reference
Rat dermal > 2500 (m and f) Gaines et al. (1973)
intraperitoneal > 4000 (m) Shaffer et al. (1956)
Mouse intravenous > 1600 (m) Shaffer et al. (1956)
intraperitoneal > 10 000 Shaffer et al. (1956)
intraperitoneal 5470 (m) Nomiyama et al. (1965)
subcutaneous 5540 (m) Nomiyama et al. (1965)
Rabbit dermal > 10 000 Elsea (1954)
Dog intravenous > 1800 (m) Fogleman (1954)
Cat intravenous > 1750 (m and f) Shaffer et al. (1956)
a m = males; f = females
Amitrole applied in water formulations to the unabraded skin of
rabbits for 24 h caused a very mild and reversible erythema (Elsea,
1954). Intraperitoneal administration in mice and rats and
intravenous administration in either mice, dogs or cats produced no
signs of toxicity (Fogleman, 1954).
No toxicity was observed in rats after inhalation of amitrole
following either head-only (approximately 50 µg/litre) or whole-body
(approximately 25 µg/litre) exposure for a period of one hour
(MacDonald & Pullinger, 1976).
7.2 Short-term exposure
7.2.1 Oral
7.2.1.1 Dietary
When groups of Carworth Farm male and female rats (five per
group) were administered amitrole in the diet at dose levels of 0,
100, 1000 or 10 000 mg/kg for 63 days, reduced body weight gain for
both males and females was observed at the two highest dose levels,
this being accompanied by reduced food consumption. There were no
deaths or clinical signs of toxicity. Histo-pathological examination
of the liver, kidney, portions of the small intestine, spleen, and
testes revealed increased vacuolization of the liver cells around
the central vein and steatosis at the two highest dose levels
(Fogleman, 1954).
Mayberry (1968) studied the effects on the thyroid of a dietary
level of 1000 mg amitrole/kg in rats during 83 days and compared
this to the effects of other anti-thyroid chemicals,
propylthiouracil (1000 mg/kg) and potassium chlorate (1000 mg/kg).
At various time intervals, starting with 3 days, the relative
thyroid weight and total iodine content of the thyroid were
measured. An increase in thyroid weight and a decrease of total
iodine were observed within the amitrole group; this was already
observable after 3 days and becoming more pronounced during the
course of the experiment. The effects of propylthiouracil were
comparable, but, in the case of potassium chlorate, the weight
increase was less pronounced and the iodine content was lower than
with amitrole. In another experiment, uptake and release of
radioactive iodine was measured after a single 131I injection to a
control group of rats and to a group simultaneously receiving 10 mg
amitrole subcutaneously. Animals were killed after 1, 2, 3, 4, 5 or
6 days. The t´ for 131I in the thyroid was 4.9 and 1.3 days for
control and amitrole-treated animals, respectively. Separation by
paper chromatography of 131I-containing thyroid fractions showed
that levels of monoiodotyrosine (MIT) were increased, diiodotyrosine
(DIT) were constant and T3 and T4 were markedly reduced. The
author concluded that amitrole not only interferes with
organification of iodine but also inhibits the coupling of
iodotyrosines to form iodothyronines (Mayberry, 1968).
The effect of amitrole on thyroid hormones was studied by
giving groups of male Sprague-Dawley rats (20 per dose level)
amitrole (94.6% pure) in the diet at dose levels of 0, 30, 100 or
300 mg/kg during 28 days, followed by a recovery period of 28 days
(Babish, 1977). The assessment of thyroid function was performed by
measuring T3 and T4 in blood by a radioimmuno-assay. On days 3, 7,
14, 21 and 28 of the treatment period and on days 19, 21 and 28 of
the post-treatment period, blood samples were collected from two
animals which were then killed for autopsy. There were no adverse
effects on the general health of the rats during the treatment or
post-treatment period. Consumption of 100 or 300 mg amitrole/kg diet
significantly depressed body weights during the 28-day treatment
period. The mean weekly body weights in the rats given 100 mg/kg
returned to control values by the third week of the post-treatment
period, while the mean weights of animals in the highest-dose group
did not return to control values during the post-treatment period.
The depression of body weights correlated with decreased food
consumption.
Serum T3 levels were significantly depressed by day 7 at
300 mg/kg (about 50%) and by day 14 at 100 mg/kg/diet (about 40%).
An inexplicable return to control values was seen 21 days into the
treatment period, followed by continued depression of T3 values on
day 28 of the treatment period. The depression of T3 appeared to
be dose related after 4 weeks of treatment. All treatments exhibited
essentially normal T3 levels by day 19 of the post-treatment
period. T4 levels followed exactly the same pattern as those of
T3. However, the T3/T4 ratio (which fluctuated between 12 and
18 in control rats) increased as the dose increased, being highest
at 300 mg/kg after 14 days of treatment.
From this study it may be concluded that amitrole, at levels of
100 mg/kg diet or more, rapidly suppressed T3 and T4 hormone
levels and maintained the depressed levels during the treatment
period. Both T3 and T4 levels returned to control values within
three weeks following withdrawal of amitrole from the diet. The
no-observed-adverse-effect level (NOAEL) in this study was
30 mg/kg/diet (Babish, 1977).
Fregly (1968) investigated the dose-response relationship
between amitrole administered in the diet and a variety of clinical
parameters in order to establish the minimal dose with an effect on
thyroid activity. Groups of male Spruce Farm strain rats (10 per
dose level) were administered amitrole in the diet at dose levels of
0, 2, 10 and 50 mg/kg diet for 13 weeks. Body weight gain, food
consumption, haematocrit, haemoglobin concentration and rate of
oxygen consumption were unaffected by the treatment. Mean body
temperature was slightly increased but only at 50 mg/kg. During week
12, uptake of radioactive iodine was measured at various times
between 22-53 h after intraperitoneal injection of 131I. A
slightly lower uptake was found at the highest dose level. At the
end of the study, radioactivity in the thyroid gland, excised 24 h
after intraperitoneal injection, was slightly decreased in all
groups. At the end of the study, the protein-bound iodine (PBI) in
blood, measured as an indicator for the concentration of thyroid
hormones, was decreased at all dose levels. The values were
51 µg/litre (control) and 37, 38 and 33 µg/litre for the 0, 2, 10
and 50 mg/kg groups, respectively. In a second experiment the PBI
levels were not affected by treatment with amitrole at 0.25 and
0.5 mg/kg diet. Values were 32 µg/litre in controls and 39 and
45 µg/litre, respectively, in treated groups. It should be noted,
however, that PBI control values measured in the second experiment
were much lower than those measured in the first experiment. This
implies that there was no biologically significant effect on PBI
since all values were within the same range. The thyroid weight was
increased significantly only in the 50-mg/kg group. The number of
blood vessels/thyroid section, which is a very sensitive measure of
histopathological changes in the thyroid, was increased at 10 and
50 mg/kg. It can be concluded that 2 mg/kg diet was the NOAEL in
this study.
Several short-term studies were carried out by Den Tonkelaar &
Kroes (1974) in order to establish a no-observed-effect level on
thyroid function tests. In all experiments the uptake of 131I by
the thyroid was measured in an in vivo test, 6, 24 and 48 h after
the intraperitoneal administration of 0.6 µc 131I per animal. In
addition, thyroid weight and PBI were measured and the thyroid was
studied histopathologically.
In the first experiment, four groups of eight female Wistar
rats received, respectively, 0, 2, 20 and 200 mg amitrole/kg in the
diet for 6 weeks. After 5 days and 6 weeks the uptake of 131I was
measured. On both occasions a significantly increased uptake was
found in the 200-mg/kg group 6 h after injection, which decreased
fairly rapidly after 24 and 48 h. At that time the radioactivity was
lower than that of the controls. The thyroid weight was increased in
the 200-mg/kg group and histopathologically goitre was found only in
this group.
In the second experiment, eight female animals per group
received, respectively, 0, 20, 50 and 200 mg/kg diet for 6 weeks,
and similar effects were found in the 200-mg/kg group to those
observed in the first experiment. In addition, a significant
decrease in PBI was observed at the end of the experiment compared
with the control value. At 50 mg/kg, a statistically increased
uptake was found 6 h after injection of 131I. However, in this
case the radioactivity in the thyroid remained higher than that in
the controls after 24 and 48 h. Histopathologically only a very
slight activation was found. However, the 200-mg/kg group showed
strong activation and goitre.
In the third experiment 0, 20, 50 and 200 mg/kg diet were given
to 10 female animals per group during 13 weeks. The uptake of 131I
by the thyroid was significantly increased at 200 and 50 mg/kg after
6 and 12 weeks. The difference between the groups was that at
50 mg/kg the radioactivity in the thyroid remained high after 24 and
48 h, whereas with 200 mg/kg a very high uptake was found 6 h after
injection of 131I but this was followed by a rapid decrease, with
still lower values than the controls after 48 h. At 200 mg/kg the
PBI was decreased and the thyroid/body weight ratio increased by a
factor of 6. At 50 mg/kg only a slightly increased relative thyroid
weight was found. Histologically, a strong activation and goitre
were found at 200 mg/kg, and a slight activation at 50 mg/kg. In
this experiment, a tendency to a higher uptake of 131I was found
in the 20-mg/kg group.
The above-mentioned experiments were carried out with a
relatively low iodine content in the diet (about 0.2-0.3 mg/kg
diet). In the fourth experiment, a diet containing 2 mg iodine/kg
was used. In this experiment, eight female rats per group received,
respectively, 0, 20, 50, 200 and 500 mg amitrole/kg in the diet for
6 weeks to see whether iodine could protect against the antithyroid
action of amitrole. At 500 mg/kg, a small increase in iodine uptake
was found 5 h after 131I injection, but thereafter there was a
very rapid decrease. At 200 mg/kg, the uptake was much higher and
the same type of decrease was found as in the other experiments,
whereas at 50 mg/kg a significantly increased thyroid radioactivity
was found at all times. PBI was decreased at 200 and 500 mg/kg only.
Histopathologically, goitre and strongly activated thyroids were
found at the two highest dose levels. Some activation was found in
the 50-mg/kg group and a very slight activation was also found in
the 20-mg/kg group. It can be concluded that measurement of 131I
uptake at different time points is a sensitive method for the
effects of amitrole on the thyroid. At 20 mg/kg only slight effects
were found on uptake and thyroid histopathology. The NOAEL was
2 mg/kg diet, equivalent to 0.1 mg/kg body weight.
7.2.1.2 Drinking-water
When groups of male albino rats (10 per dose level) were
administered amitrole in the drinking-water at dose levels of 0, 50,
250 or 1250 mg/litre for 106 days, there was a dose-related decrease
in body weight gain in all treated groups with a corresponding
reduction in food and water intake. There were no clinical signs of
toxicity. At the end of the study, histopathological examination was
performed on the thyroid, hypophysis, liver, kidney, spleen,
stomach, small intestine, large intestine, bladder, testis, adrenal
and lung. The major gross pathological finding was an increase in
size and vascularity of the thyroid. At the high dose level, colloid
was absent in large and medium size thyroid follicles. High-dose
animals also displayed liver steatosis (Bagdon et al., 1956).
The time-course for development of goitre in rats was examined
by Strum & Karnovsky (1971). Sprague-Dawley rats were administered
amitrole in the drinking-water (2.5 mg/ml), and the thyroid of each
animal was examined by light microscopy at various periods from 3
days to 6 months. Each rat drank approximately 30 ml water per day.
After 3 days, the thyroid size was unchanged although cellular
changes were apparent. By one week, the thyroid was twice its normal
size with marked structural changes. These changes continued to
progress with prolonged administration of amitrole. Goitre formation
was accompanied by increased vascularity and decreased colloid
content in the follicular cells. Electron microscopy revealed
pronounced dilation of the endoplasmic reticulum of thyroid cells.
Thyroid peroxidase activity progressively decreased with
administration of amitrole.
The effects of amitrole on thyroid histology were examined in
seven groups of five female Wistar rats (weighing about 200 g),
which were given amitrole in their drinking-water (2.5 mg/ml) and
killed after 1, 2, 3, 10, 30, 50 or 100 days (Tsuda et al., 1973).
Water consumption was not reported. After 1 and 2 days of exposure
the only change noted was a slight enlargement of some endoplasmic
cisternae of the follicular cells. After 3 days the thyroid gland
was slightly enlarged, follicular colloid was slightly reduced and
in some follicular cells the cisternae were clearly dilated and
stained more lightly for peroxidase activity than did normal cells.
By 10 days the glands had doubled in size, the follicular epithelium
consisted of low, columnar cells, and colloid had been severely
depleted. Nuclei had become located basally and slightly elongated
microvilli projected into the lumen. Peroxidase activity was no
longer detected in the endoplasmic reticulum cisternae, but in
portions of perinuclear cisternae. These changes had progressed in
the 30-day samples, so that the glands were now several times their
normal size. In addition, fibrous thickening of both stroma and
capsule was prominent and cisternal peroxidase activity was absent.
Administration for 50 days resulted in increased irregularity in
follicular size, more prominent papillary growth of the follicular
epithelium and greatly diminished peroxidase activity throughout the
cells.
Histopathological changes induced by amitrole in the liver of
mice were investigated by Reitze & Seitz (1985). Groups of male
albino mice were exposed to amitrole in the drinking-water at dose
levels of 0.5%, 1.0% or 2% for 30 days (water consumption not
reported). Light microscopy revealed dose-related hypertrophy of
hepatocytes, increased pyknotic nucleoli, and increased vacuoles in
the cytoplasm. Electron microscopy revealed also a dose-related
proliferation of smooth endoplasmic reticulum.
7.2.1.3 Intubation
No data available.
7.2.2 Inhalational
Groups of Fischer-344 rats (15 of each sex per dose level) were
exposed to an atmosphere containing amitrole (94.6% pure) at
concentrations of 0, 0.1, 0.32, 0.99 or 4.05 mg/litre (nominal
concentrations adjusted for non-nebulized material) for 5 h/day, 5
times per week, for 4 weeks (particle size not provided). There were
no adverse effects on behaviour, and no body weight changes were
noted. T4 levels were significantly depressed by the 27th day at
the two highest dose levels. T3 levels were significantly
depressed by 14 days at all but the lowest dose level. Pathological
changes were confined to the thyroid, and hyperplasia was noted at
all but the lowest dose level (Cox & Re, 1978).
7.2.3 Intraperitoneal
Alexander (1959a) investigated the uptake of 131I by the
thyroid gland in Sprague-Dawley rats following intraperitoneal
injection of approximately 5 or 250 mg/kg body weight. At both dose
levels thyroid 131I uptake was inhibited, whereas catalase
activity was decreased by about 50% at the highest dose level only.
When 328 White Leghorn 3-day old chicks were injected with
amitrole (500 or 1000 mg/kg day), 5 days per week for 5 weeks,
increases in the relative thyroid-to-body weight ratio was observed
in all birds from day 10 onward. In addition, two groups of chickens
were injected the same doses of amitrole but for 17 consecutive
days. At the cessation of amitrole treatment, an increase in the
relative thyroid-to-body weight ratio was observed until day 13;
this was followed by a decrease and then a stabilization, which
occurred between days 17 and 41. However, the ratio never attained
the levels observed in control animals. Histopathological
examination of the thyroid gland revealed epithelial hyperplasia,
hyperaemia, obliteration of the follicular lumina and disappearance
of the colloid. In birds that were injected with amitrole only for
17 days, the thyroid histology returned to normal two weeks after
treatment (Wishe et al., 1979).
7.3 Long-term exposure
7.3.1 Oral
7.3.1.1 Mouse
Reversible thyroid hyperplasia has been reported during
long-term feeding studies with amitrole at levels of 1000 mg/kg diet
in both C3H and C57BL mice (Feinstein et al., 1978a). The
acatalasemic C3H mice survived longer on the amitrole diet than did
their normal catalasemic counterparts (mean survival times in weeks,
both sexes combined, were 35 ± 10, n = 141, and 26 ± 10, n = 146,
respectively, P < 0.001). Similar differences were observed with
C57BL/6 mice, although group sizes were much smaller (57 ± 5, n =
12, and 42 ± 7, n = 10, respectively). All mice given the treated
diet had a reduced body weight gain compared with mice given the
normal diet. In those mice for which the amitrole diet was withdrawn
at 12 weeks, the thyroid weight reduced in size gradually but the
gland was still enlarged after 60 weeks. A larger proportion of the
acatalasemic C3H mice developed liver tumours, as compared with
normal catalasemic C3H mice. Out of 87 mice in the acatalsemic
group, 21 developed liver tumours that were detected earlier
(beginning at 35 weeks) compared with the normal catalase mice (6/85
beginning at week 50) (Feinstein et al., 1978b).
In a life-time study in NMRI mice (dose levels 0, 1, 10,
100 mg/kg diet), the appearance, behaviour, food intakes, body
weights and survival times of the treated mice did not differ from
those of the controls. The frequency of pituitary hyperaemia was
slightly elevated in the high-dose group; no treatment-related
histological lesions were otherwise found. The frequency of types
and distribution of tumours in the control and treated groups were
similar. The thyroid weights were elevated in male high-dose group
mice at all dose levels and were up to three times the weights in
the control group. The percentage of iodine accumulation and the
iodine level in the thyroid were elevated in the male mice of the
100-mg/kg group. The sum of PBI in the male mice was elevated nine
months after study initiation, but was depressed at later test
dates. Comparable results were observed in the female high-dose
group mice. However, the deviations from control group values were
generally smaller than in the males, and were not significant in
most cases (Weber & Patrick, 1978; Steinhoff & Boehme, 1979b).
7.3.1.2 Rat
The long-term effects of oral administration of amitrole in
rats have been described in two detailed reports by Keller (1959)
and Johnson et al. (1981). The details and results of these studies
are given below.
In the study by Keller (1959), groups of Carworth Farm Wistar
rats (35 of each sex per dose level) were administered amitrole in
the diet at dose levels of 0, 10, 50 or 100 mg/kg diet for two
years. After 13 and 68 weeks, 5 and 3 animals of each sex and dose
level, respectively, were killed for organ weight measurement and
histopathological examination. A separate group received 500 mg/kg
diet for 19 weeks, followed by the control diet for 7 weeks, and
then were killed. In this group, body weight gain and food
consumption were markedly reduced during the amitrole
administration. Animals in all groups, including the controls,
suffered from apparent respiratory infection and 67 of them died,
but there was no relationship with the treatment. Body weight gain
was reduced at 100 mg/kg in male animals during the first 13 weeks
of the study. After 68 and 104 weeks of treatment, relative thyroid
weight was increased at 100 mg/kg (not measured after 13 weeks).
Histopathological examination after 13 weeks showed hyperplasia and
hypertrophy of the thyroid at 500 mg/kg; these effects were found to
be reversible. Histopathological changes in the thyroid were also
seen at 100 mg/kg and in one animal at 50 mg/kg. At 68 weeks three
animals given 50 mg/kg showed definitive evidence of hyperplasia,
while all animals given 100 mg/kg displayed hyperplasia and
hyperfunctioning of the thyroid. At 104 weeks tumours were found
(see section 7.7.2). Based on thyroid hyperplasia, the NOAEL was
10 mg/kg diet (equivalent to 0.5 mg/kg body weight).
In a chronic toxicity study by Johnson et al. (1981), groups of
Fischer-344 rats (75 of each sex per dose level) were administered
amitrole. Group A were the controls. Group B rats were fed 5 mg
amitrole/kg in their diet during weeks 1-39 and then 100 mg/kg
during weeks 40-115 (for males) or 40-119 (for females). Rats in
groups C, D and E received amitrole in their diet at pulsed
intervals (alternate 4-week periods) of 1, 3 and 10 mg/kg,
respectively, during weeks 1-39 and 20, 60 and 100 mg/kg,
respectively, during weeks 40-115 (for males) or 40-199 (for
females). There were no treatment-related clinical signs of toxicity
or changes in body weight or food consumption. There were no
consistent effects on serum T3 and T4 levels. Thyroid weight was
increased in both males and females in groups B and E after 60 weeks
and at termination. There were no treatment-related pathological
changes up to 36 weeks (when only the lower dose levels were
administered). Follicular epithelial hyperplasia in the thyroid was
noted in groups B, D and E and to a much lesser extent in group C.
An increased incidence in thyroid tumours was observed in male and
female rats of groups B and E and in the male animals of group D.
There was no significant difference in tumour incidence between
groups B and E. It should be noted that this study was poorly
reported.
When amitrole was administered to groups of Wistar rats (75 of
each sex) at concentrations in the feed of 0, 1, 10 or 100 mg/kg, no
effect on body weight gain or food intake was observed but a slight
decrease in survival time was found at 100 mg/kg. Thyroid weight was
increased at 100 mg/kg as was uptake of 131I by the thyroid,
measured 24 h after oral administration of 131I. For this
measurement, five animals of each sex per group were killed at 3, 6,
12 and 24 months. PBI, measured as the ratio between radioactivity
in plasma protein and total plasma, was not affected. At the highest
dose level, elevated incidences of haemorrhage and hyperaemia of the
pituitary gland, as well as a very high rate of cystically dilated
thyroid follicles, were seen. The tumour incidence is given in
section 7.7.2. The NOAEL was 10 mg/kg diet, equivalent to 0.57
(males) or 0.85 (females) mg/kg body weight (Weber & Patschke 1978;
Steinhoff & Boehme, 1979a).
Authors who have studied the time-course of the response of the
thyroid to amitrole treatment (e.g., Strum & Karnovsky, 1971; Tsuda
et al., 1973; Wynford-Thomas et al., 1983) have shown that, after a
short lag phase of a few days, there is a rapid rise in TSH that is
paralleled by thyroid hypertrophy and hyperplasia. These effects
peak and plateau after 3-4 months and thereafter remain relatively
stable despite further exposure. A number of studies have shown that
the goitrogenic action of amitrole is reversible on cessation of
exposure (Jukes & Shaffer, 1960).
7.3.1.3 Other species
Other species in which long-term amitrole treatment has been
studied are the hamster and dog.
In a carcinogenicity study on hamsters (Steinhoff & Boehme,
1978; Steinhoff et al., 1983; see section 7.7), there were no
pathological changes at dose levels of up to 100 mg/kg diet. In a
one-year study in dogs, amitrole was given in capsules at dose
levels of 0, 0.25, 1.25, 2.50 and 12.5 mg/kg body weight per day,
6 days/week. There were no clinical signs of toxicity or
pharmacological effects. Haematological, biochemical and urinalysis
parameters were comparable to those of control dogs and were within
normal limits. The dogs fed 12.5 mg/kg per day had a pale pancreas.
Histopathological examination of all dogs did not reveal any
treatment-related effects. The thyroid, in particular, was normal at
all dose levels (Weir, 1958; Hodge et al., 1966).
7.3.2 Other routes
In a chronic 104-week study, 25 male and 25 female rats
(Charles River strain) were exposed (head-nose only) to an amitrole
aerosol (the purity of the amitrole used was not specified) for one
hour each week. An aqueous 0.24% (w/v) solution of amitrole was used
to generate the aerosol. The mean analytical concentration in the
inhalation chamber was 2 mg aerosol per litre of air; based on dry
amitrole, the level was 5 µg/litre air. A control group was exposed
to a water aerosol. No differences between the control group animals
and those exposed to the test substance were found in the mortality,
appearance, behaviour or body weight development. No
treatment-related changes were observed at necropsy. No differences
in the thyroid or liver weights, or in the incidence of tumours,
existed between the two groups of animals (Grapenthien, 1972).
In an inhalation study involving intermittent treatment, groups
of 75 Fischer rats per dose and of each sex were exposed to aerosols
at nominal amitrole levels of 0, 50, or 500 µg/litre air (the purity
of the amitrole used was not specified). The actual amitrole
concentrations in the low-dose group varied between 15.8 and
32.2 µg/litre air on different days of exposure, and the levels
measured in the high-dose group ranged between 97.9 and
376.4 µg/litre air. The animals were exposed for 5 h per day on 5
days per week. The treatment phases during weeks 1-13, 40-52 and
78-90 were interrupted by treatment-free intervals. Interim
necropsies of five animals per dose group and of each sex were
performed after 3, 9 and 18 months, and the study was concluded
after 24 months. A total of 28 rats died in week 51 due to a defect
in the air conditioning system, which led to an increase in the room
temperature. Treatment of the high-dose group was thereupon
concluded, and the surviving animals were necropsied.
The food intake and body weight gain were decreased in the
high-dose group, and the rate of mortality was elevated.
Decreases in the T3 (significant) and T4 (non-significant)
levels were only observed in the high-dose group, this being
assessed in the 13th week of the study. However, values in the
amitrole-treated animals were greater than, or equal to, those of
control rats at all other test dates (weeks 39, 52, 78, 91 and 104).
Epithelial hyperplasia of the thyroid follicles was observed in both
dose groups at the end of the first treatment interval (week 13).
This observation was no longer made after a treatment-free interval
of 24 weeks, but the thyroid weights relative to those in the
control animals were elevated in both dose groups. Follicular
epithelial hyperplasia was again present in most of the animals of
both treatment groups at the end of the second treatment phase (week
51). This observation was still made after a treatment-free interval
of 26 weeks, which indicates that complete reversion no longer
occurred at this time at an amitrole level of 50 µg/litre air.
Neoplasms of the thyroid (adenomas and adenocarcinomas) were found
in addition to hyperplasia at terminal necropsy (Becci, 1983).
Twenty-five male and 25 female rats (Charles River strain) were
dermally exposed to an 0.239% aqueous solution of amitrole (the
purity of the amitrole used was not specified) once weekly for 30
min over a period of 23 months (total of 100 exposures). The
treatment volume was 1 ml/kg body weight, and about 20% of the body
area was treated. The dermal exposure to amitrole thus amounted to
2.39 mg/kg body weight per week. The treatment did not cause skin
damage. No differences between the control group and animals exposed
to the test substance were found with respect to mortality,
appearance, behaviour or body weight development. No
treatment-related alterations were determined at necropsy. No
differences in the thyroid or liver weights, or in the incidence of
tumours, were found between the two groups of animals (Rausina,
1972).
7.4 Skin and eye irritation; skin sensitisation
The potential for dermal irritation by amitrole was examined in
rabbits over a 24-h period following a single application of between
10 and 100 mg/kg body weight (Elsea, 1954). Mild erythema was
observed at the high-dose level only. By 48 h, the skin appeared
normal. The potential for eye irritation by amitrole was examined in
rabbits following application of 3 mg into the conjunctival sac of
the left eye (Elsea, 1954). Observations were made at 1, 4, and 24 h
and at daily intervals for 6 days. Mild irritation was observed at
4 h in all animals, but the majority of animals had recovered by
24 h.
Amitrole was tested for possible dermal sensitization potential
in guinea-pigs using the Magnusson-Kligman maximization test with
Freund's adjuvant. The concentrations employed were 2.5% for
intracutaneous induction, 25% for topical induction, and 12% for the
first and second challenges. Evidence for moderate skin-sensitizing
potential in amitrole was found after both challenges (Mihail,
1984).
No skin-sensitizing effect was observed in a Klecak open
epicutaneous test involving treatment of three groups of animals
with 3%, 10% or 30% amitrole formulations in the induction phase
(Mihail, 1985).
7.5 Reproduction, embryotoxicity and teratogenicity
7.5.1 Reproduction
In a preliminary one-generation reproduction study by Gaines
et al. (1973), groups of 10 male and 10 female rats were fed
amitrole in the diet at concentrations of 0, 500 or 1000 mg/kg for
55 days before pair-mating. The offspring were weaned at 21 days.
Complete autopsies were performed on the parents after a total
exposure of 107-110 days. Ten weaning rats from each dose groups
were killed. Mean body weight gain was reduced at all dose levels.
The average number of pups per litter was significantly reduced at
all dose levels, as were the number surviving to weaning. The body
weight of pups at weaning was also reduced. Relative kidney, spleen
and liver weights were also reduced in parents following treatment,
while thyroid hyperplasia was noted in all treated animals.
In a subsequent multi-generation study by Gaines et al. (1973),
groups of 10 male and 10 female rats were fed amitrole at dietary
levels of 0, 25 or 100 mg/kg for 61 and 173 days before pair-mating
to produce the F1A and the F1B generations, respectively. The
thymus and spleen were examined in weanling rats in the F1A
generation. There was no treatment-related effect on body weight
gain in the FO animals. Hyperplasia of the thyroid was observed in
all animals at the highest dose level but not at 25 mg/kg.
Reproduction parameters were normal at these dose levels. A slight
decrease in body weight gain was noted at 25 and 100 mg/kg in pups
of the F1A and F1B generation. Pathological examination revealed
a slight but significant decrease in liver weight at 25 and
100 mg/kg (male pups) and at 100 mg/kg (female pups). The thymus and
spleen sizes were normal and no histopathological changes could be
detected. F2A generation rats showed a decrease in the number of
litters at 100 mg/kg but there were no other changes, such as
survival to weaning and mean body weight at weaning.
7.5.2 Embryotoxicity and teratology
Teratology studies have been performed in rats, mice and
chickens.
In a study by Gaines et al. (1973), three groups of pregnant
rats were administered amitrole by gavage at dose levels of 0, 20 or
100 mg/kg body weight per day on days 7 to 15 of gestation, and the
animals were allowed to litter and to wean. There was no evidence of
gross abnormalities among the pups.
In a further teratology study on rats by Machemer (1977b),
groups of 20 presumed pregnant rats (strain FB30, Long-Evans) were
administered amitrole by gavage at dose levels of 0, 100, 300 or
1000 mg/kg body weight per day on days 6 to 15 of gestation, and
fetuses were examined on day 20 of gestation. There were no deaths
or signs of toxicity at any dose level. Body weight gain was not
affected by treatment. There were no treatment-related effects on
the resorption rate, fetal weight, number of live fetuses, placental
weight or sex ratio. There was no treatment-related increase in
gross, skeletal or visceral malformation.
In a study by Tjalve (1974), pregnant mice were administered
amitrole at 500, 1000, 2500 and 5000 mg/litre in the drinking-water
on days 6-18 of pregnancy. There was a marked decrease (22-28%) in
body weight gain in the dams and pronounced retardation in the
development in their fetuses at dose levels > 1000 mg/litre. At
the highest dose level used, maternal toxicity was associated with
an increase in the rate of resorption. No teratogenic effects were
observed at any dose level.
Teratogenicity in chickens was investigated by injecting the
yolk sac of eggs with amitrole at dose levels of between 0.5 and
40 mg at 0, 24, 48 and 96 h of incubation (Landauer et al., 1971).
Dose-dependent abnormalities of the beak were found to be present in
chickens following the administration of 20-40 mg amitrole at 24 and
48 h. When injected after 96 h of incubation, beak abnormalities
could be found at dose levels of 10, 20 and 40 mg at a rate of 20,
48, and 60%, respectively. No effects were seen at dose levels up to
and including 2 mg/egg.
7.6 Mutagenicity and related end-points
A referenced summary of the test results with amitrole is given
in Table 4. The important features of these data are described
below.
7.6.1 DNA damage and repair
The possibility of DNA damage being induced by amitrole has
been investigated frequently and in a number of different ways. In
bacteria, the results have been negative, except in one experiment
with the rec assay, in which exogenous metabolic activation was
provided by "liver" preparations from a mollusc and a fish. Among
assays which could be evaluated, a DNA repair assay in yeast gave a
positive result, as did a repair assay in mammalian cells.
7.6.2 Mutation
One study in a single laboratory with Escherichia coli and
Salmonella typhimurium strains gave significant responses (Venitt
& Crofton-Sleigh, 1981). Amitrole did not induce joint mutations in
histidine-requiring mutants of S. typhimurium (Andersen et al.,
(1972). An equivocal response was obtained in another bacterial
mutation assay, but many other in vitro assays gave negative
results. A significant result was obtained in a mouse peritoneal
host-mediated assay with S. typhimurium (Simmon et al., 1979). No
mutation induction has been observed in yeast or fungi. In
Drosophila melanogaster, a significant response was obtained with
a wing-spot test in a single study, but not with several sex-linked
recessive assays. Mutations were not induced in mouse lymphoma
cells, but hprt locus and Na+/K+ ATPase locus mutations were
induced in Syrian hamster embryo cells (Tsutsui et al., 1984). These
latter results may hold particular significance in view of other
properties of these cells described in sections 7.6.4 and 7.6.5.
7.6.3 Chromosome damage
In yeast, there is conflicting evidence for recombinogenic
activity (intragenic and mitotic recombination), while numerical
chromosomal aberrations were induced in three assays. Structural
chromosomal damage was not induced by amitrole in cultured mammalian
cells, but the frequency of sister-chromatid exchanges was increased
in a single study. No effects of amitrole were observed in mice
subjected to bone marrow micronucleus tests or male dominant lethal
tests.
7.6.4 Cell transformation
Assays for anchorage-independent growth and cell transformation
in several systems consistently gave positive results.
Table 4. Summary of mutagenicity and related end-point studies on amitrole
Test Organism Result LED or HIDe Reference
-S9h +S9i
Microorganisms
Prophage induction E. coli 58-161 enVA, lambda n.t. - 10 000 µg/ml Thomson (1981)
prophage
Prophage induction E. coli GY5027, GY4015 n.t. - 2000 µg/plate Mamber et al. (1984)
Rec assay Bacillus subtilis H17 rec+, M45 rec- - n.t. µg/plate Shirasu et al. (1976)
Rec assay Bacillus subtilis H17 rec+, M45 rec- - +a 1000 µg/plate Kada (1981)
Rec assay E. coli JC 2921, 9238, 8471, 5519, - - 500 µg/ml Ichinotsubo et al. (1981)
7623, 7689
Rec assay E. coli WP2, WP100 n.t. - 4000 µg/ml Mamber et al. (1983)
Pol assay E. coli pol A1, pol A+ - n.t. µg/plate Bamford et al. (1976)
Pol assay E. coli WP3110, p3478 - - 333 µg/plate Rosenkranz et al. (1981)
Differential killing E. coli WP2, WP67, CM 871 - - 1000 µg/ml Tweats (1981)
Reverse mutation S. typhimurium TA1535, TA1537, TA1538 - - 100 µg/plate Brusick (1975)
Reverse mutation S. typhimurium TA1535, TA1538, - - 1000 µg/plate Prince (1977)
TA98, TA100
Reverse mutation S. typhimurium TA1535, TA1536, - - 2000 µg/plate Carere et al. (1978)
TA1537, TA1538
Table 4 (contd).
Test Organism Result LED or HIDe Reference
-S9h +S9i
Reverse mutation S. typhimurium TA1535, TA1538 - - 250 µg/plate Rosenkranz & Poirier
(1979)
Forward mutation S. typhimurium TM 677 - - 100 µg/ml Skopek et al. (1981)
Reverse mutation S. typhimurium TA1535, TA1537, - - 12 500 µg/plate Herbold (1980)
TA98, TA100
Reverse mutation S. typhimurium TA1535, TA1537, - - 2000 µg/plate Brooks & Dean (1981)
TA1538, TA98, TA100, TA92
Reverse mutation S. typhimurium TA1537, TA98, TA100 - - 5000 µg/plate MacDonald (1981)
Reverse mutation S. typhimurium TA1535, TA1537, TA1538, - - 10 000 µg/plate Richold & Jones (1981)
TA98, TA100
Reverse mutation S. typhimurium TA1535, TA1537, TA1538, - - 2000 µg/plate Rowland & Severn (1981)
TA98, TA100
Reverse mutation S. typhimurium TA1535, TA1537, TA1538, n.t. - 2500 µg/plate Trueman (1981)
TA98, TA100
Reverse mutation S. typhimurium TA98, TA100 n.d. + f Venitt & Crofton-Sleigh
(1981)
Reverse mutation S. typhimurium TA98, TA100 ± ± 500 µg/ml Hubbard et al. (1981)
Reverse mutation S. typhimurium TA1535, TA1537, TA98 - - 1000 µg/ml Gatehouse (1981)
Reverse mutation S. typhimurium TA1535, TA1537, TA1538, - - 5000 µg/plate Moriya et al. (1983)
TA98, TA100
Table 4 (contd).
Test Organism Result LED or HIDe Reference
-S9h +S9i
Reverse mutation S. typhimurium TA1535, TA1537, TA1538, - - 333 µg/plate Dunkel et al. (1984)b
TA988, TA100
Reverse mutation E. coli WP2, WP2uvrA nd + f Venitt & Crofton-Sleigh
(1981)
Reverse mutation E. coli WP2uvrA - - 500 µg/plate Gatehouse (1981)
Reverse mutation E. coli WP2uvrA - - 5000 µg/plate Moriya et al. (1983)
Reverse mutation E. coli WP2uvrA - - 333 µg/plate Dunkel et al. (1984)b
Forward mutation E. coli CHY832 + - 2500 µg/ml Hayes et al. (1984)
Forward mutation Streptomyces coelicolor A3(2) ± n.t. µg/plate Carere et al. (1978)
Host mediated S. typhimurium TA1950 in NMRI mouse - n.t. 2900 µmol/kg Braun et al. (1977)
reverse mutation
Host mediated S. typhimurium TA1530, TA1535, TA1538 + n.t. 1585 mg/kg i.p. Simmon et al. (1979)
reverse mutation in Swiss-Webster mouse
DNA repair Saccharomyces cerevisiae 197/2d + - 100 µg/ml Sharp & Parry (1981b)
rad 3, rad 18, rad 52, trp 2
Reverse mutation